Smith and Nephew has introduced a handheld imaging device, MolecuLight i:X, in Europe to allow immediate measurement of wound surface area.

Manufactured by Canadian medical imaging firm MolecuLight, the device uses fluorescence to visualise the presence and distribution of potentially harmful bacteria in wounds.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

MolecuLight i:X is developed to address the concerns with current, inaccurate wound assessments made with the naked eye.

The device is intended to facilitate the right treatment at the right time for the patient. It also aids in guide sampling and debridement of wounds, monitors its progression, improves patient engagement, and simplifies documentation.

Smith and Nephew Wound global marketing senior vice-president Paolo Di Vincenzo said: “The MolecuLight i:X enables healthcare professionals to see what they have never been able to see before.

“We believe it is set to start a revolution in wound care clinical practice.”

“It strongly complements our range of advanced wound care products and we believe it is set to start a revolution in wound care clinical practice.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The MolecuLight i:X Imaging Device obtained Health Canada approval as well as CE-Mark in Europe.

As per the clinical data obtained during wound assessments, integration of the device into standard of care enabled more objective medical decisions and led to about nine times faster wound healing and 54% more accurate swabbing.

MolecuLight founder, chief scientific officer and director Dr Ralph DaCosta said: “For the first time, clinicians can accurately sample a wound in situ to determine if bacteria are present as well as more effectively debride a wound under fluorescence visualisation.

“These are fundamental areas of everyday wound care that have remained suboptimal for too long, until now.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact